Huntington's Disease: New Drug Slows Progression in Trial
A revolutionary new drug, pridopidine, has shown significant promise in slowing the progression of Huntington's disease, offering new hope to UK families affected by the genetic condition.
Category : Search result: Prilenia Therapeutics
Brothers denied insurance for life-saving gene therapy
Two brothers in Chicago face a devastating insurance denial for a groundbreaking gene therapy treatment, highlighting a critical gap in US healthcare coverage for rare diseases.
Page 1 of 1